Sort
35,931 grants matching “parkinsons”
Maintaining Mitochondrial Health into Old Age
$360,081Shane Rea · University Of Washington · R01 · FY2018 · AG
Multimodal Correlation of Imaging Markers and Neuropathogenesis of NeuroAIDS
$360,063Jacopo Annese · University Of California, San Diego · R01 · FY2010 · MH
Transhydrogenase: Structure, Dynamics, and Mechanism
$360,050Charles David Stout · Scripps Research Institute, The · R01 · FY2015 · GM
Transhydrogenase: Structure, Dynamics, and Mechanism
$360,050Charles David Stout · Scripps Research Institute, The · R01 · FY2014 · GM
Novel Neuroprotection by Caffeine in Parkinson's Disease
$360,050Massachusetts General Hospital · R01 · FY2001 · ES
Novel Neuroprotection by Caffeine in Parkinson's Disease
$360,050Massachusetts General Hospital · R01 · FY2002 · ES
Proteomic Studies in Parkinson's Disease
$360,050University Of Washington · R01 · FY2005 · ES
Proteomic Studies in Parkinson's Disease
$360,050University Of Washington · R01 · FY2004 · ES
Oxidative stress and neurogenetic networks in Drosophila
$360,045Robert R. H Anholt · North Carolina State University Raleigh · RC1 · FY2009 · ES
Proteomics of widespread, reversible protein assemblies in aging and aggregation
$360,013Edward M Marcotte · University Of Texas At Austin · R01 · FY2014 · GM
Mechanism of Enteric Neuropathy
$360,000Shanthi K Srinivasan · Emory University · R01 · FY2015 · DK
GOALI: Heterogeneous 3D Integration of Electronic, Optical, and Structural Platform for Neural Microsystems
$360,000Euisik Yoon · Regents Of The University Of Michigan - Ann Arbor · · FY2011 · ENG
Investigation of Superoxide Dismutase I in Parkinson's Disease
$360,000Moses Leavens · Mc Laughlin Research Institute · P20 · FY2024 · GM
Epileptogenic Focus Localization and Closed-loop Control of Brain Dynamics in Epilepsy
$360,000Konstantinos S Tsakalis · Arizona State University · · FY2011 · ENG
1/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
$360,000Joseph Patrick McEvoy · Duke University · R01 · FY2009 · MH
Insulin Misfolding Dynamics and Insulin Signaling Dysfunction
$360,000Brenda F Canine · Mc Laughlin Research Institute · P20 · FY2025 · GM
Investigation of Superoxide Dismutase I in Parkinson's Disease
$360,000Moses Leavens · Mc Laughlin Research Institute · P20 · FY2025 · GM
Understanding the prefrontal mechanisms involved in the enhancement and maintenance of visual signals.
$360,000Behrad Noudoost · Montana State University - Bozeman · R01 · FY2016 · EY
A Phase II Trial of Levodopa in Angelman Syndrome
$359,978Wen-Hann Tan · Boston Children'S Hospital · R01 · FY2012 · FD
Mechanisms of cytosolic proteostasis in yeast
$359,973Kevin Anthony Morano · University Of Texas Hlth Sci Ctr Houston · R01 · FY2020 · GM
A Phase II Trial of Levodopa in Angelman Syndrome
$359,972Wen-Hann Tan · Boston Children'S Hospital · R01 · FY2010 · FD
A Phase II Trial of Levodopa in Angelman Syndrome
$359,971Wen-Hann Tan · Boston Children'S Hospital · R01 · FY2011 · FD
A Phase II Trial of Levodopa in Angelman Syndrome
$359,958Wen-Hann Tan · Boston Children'S Hospital · R01 · FY2013 · FD
An orderly approach to toxic mechanism by disorderly peptides
$359,921Andrew D Miranker · Yale University · R01 · FY2014 · GM
Cortical Connectivity and Activity Changes in Motor Preparation and Execution in 6-OHDA-Lesioned Mice
$359,907Dieter Jaeger · Emory University · P50 · FY2024 · NS